CVALF
Price
$1.81
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
47.78M
CYDY
Price
$0.26
Change
-$0.04 (-13.33%)
Updated
Jun 27 closing price
Capitalization
317.35M
31 days until earnings call
Interact to see
Advertisement

CVALF vs CYDY

Header iconCVALF vs CYDY Comparison
Open Charts CVALF vs CYDYBanner chart's image
Covalon Technologies
Price$1.81
Change-$0.00 (-0.00%)
Volume$2.41K
Capitalization47.78M
CytoDyn
Price$0.26
Change-$0.04 (-13.33%)
Volume$2.15M
Capitalization317.35M
CVALF vs CYDY Comparison Chart in %
Loading...
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVALF vs. CYDY commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVALF is a Hold and CYDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CVALF: $1.81 vs. CYDY: $0.26)
Brand notoriety: CVALF and CYDY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVALF: 43% vs. CYDY: 92%
Market capitalization -- CVALF: $47.78M vs. CYDY: $317.35M
CVALF [@Biotechnology] is valued at $47.78M. CYDY’s [@Biotechnology] market capitalization is $317.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVALF’s FA Score shows that 0 FA rating(s) are green whileCYDY’s FA Score has 1 green FA rating(s).

  • CVALF’s FA Score: 0 green, 5 red.
  • CYDY’s FA Score: 1 green, 4 red.
According to our system of comparison, CYDY is a better buy in the long-term than CVALF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVALF’s TA Score shows that 3 TA indicator(s) are bullish while CYDY’s TA Score has 3 bullish TA indicator(s).

  • CVALF’s TA Score: 3 bullish, 5 bearish.
  • CYDY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CVALF and CYDY are a bad buy in the short-term.

Price Growth

CVALF (@Biotechnology) experienced а +9.04% price change this week, while CYDY (@Biotechnology) price change was -16.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CYDY is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYDY($317M) has a higher market cap than CVALF($47.8M). CYDY YTD gains are higher at: 134.731 vs. CVALF (-19.196). CVALF has higher annual earnings (EBITDA): 4.73M vs. CYDY (-1.98M). CVALF has more cash in the bank: 18M vs. CYDY (16.4M). CVALF has less debt than CYDY: CVALF (609K) vs CYDY (27.3M). CVALF has higher revenues than CYDY: CVALF (33.8M) vs CYDY (0).
CVALFCYDYCVALF / CYDY
Capitalization47.8M317M15%
EBITDA4.73M-1.98M-239%
Gain YTD-19.196134.731-14%
P/E Ratio16.55N/A-
Revenue33.8M0-
Total Cash18M16.4M110%
Total Debt609K27.3M2%
FUNDAMENTALS RATINGS
CVALF vs CYDY: Fundamental Ratings
CVALF
CYDY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
55100
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/a10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYDY's Valuation (4) in the null industry is somewhat better than the same rating for CVALF (63). This means that CYDY’s stock grew somewhat faster than CVALF’s over the last 12 months.

CVALF's Profit vs Risk Rating (69) in the null industry is in the same range as CYDY (100). This means that CVALF’s stock grew similarly to CYDY’s over the last 12 months.

CVALF's SMR Rating (55) in the null industry is somewhat better than the same rating for CYDY (100). This means that CVALF’s stock grew somewhat faster than CYDY’s over the last 12 months.

CYDY's Price Growth Rating (40) in the null industry is in the same range as CVALF (57). This means that CYDY’s stock grew similarly to CVALF’s over the last 12 months.

CVALF's P/E Growth Rating (93) in the null industry is in the same range as CYDY (100). This means that CVALF’s stock grew similarly to CYDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVALFCYDY
RSI
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGFHY7.870.06
+0.77%
Kingfisher plc
ADMQ0.04N/A
N/A
ADM Endeavors Inc.
IPCFF16.19N/A
N/A
International Petroleum Corp. CDA
MCQEF132.57N/A
N/A
Macquarie Group, Ltd.
CNBB40.06-1.54
-3.70%
CNB Community Bancorp Inc.

CVALF and

Correlation & Price change

A.I.dvisor tells us that CVALF and ARGNF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVALF and ARGNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVALF
1D Price
Change %
CVALF100%
N/A
ARGNF - CVALF
22%
Poorly correlated
N/A
CYDY - CVALF
10%
Poorly correlated
-14.17%
GNMSF - CVALF
9%
Poorly correlated
N/A
FAMDF - CVALF
6%
Poorly correlated
N/A
CYYNF - CVALF
6%
Poorly correlated
N/A
More

CYDY and

Correlation & Price change

A.I.dvisor tells us that CYDY and RGLS have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and RGLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-14.17%
RGLS - CYDY
25%
Poorly correlated
N/A
TNXP - CYDY
22%
Poorly correlated
-1.83%
AGNPF - CYDY
21%
Poorly correlated
N/A
CLNN - CYDY
20%
Poorly correlated
-4.08%
GNNSF - CYDY
16%
Poorly correlated
N/A
More